Food and Drug Administration, HHS.
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public.
Name of Committee: Vaccines and Related Biological Products Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on July 26, 2001, 8:30 a.m. to 5:30 p.m., and on July 27, 2001, 8:30 a.m. to 3:30 p.m.
Location: Holiday Inn, Grand Ballroom, Two Montgomery Village Ave., Gaithersburg, MD.
Contact: Nancy T. Cherry or Denise H. Royster, Center for Biologics Evaluation and Research (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting.
Agenda: On July 26, 2001, the committee will hear presentations on the available safety and efficacy data for Aviron, Inc.’s cold adapted, live attenuated, trivalent influenza virus vaccine (FluMistTM). On July 27, 2001, the committee will discuss the available data and the proposed indications for FluMistTM.
Procedure: On July 26, 2001, from 10:15 a.m. to 5:30 p.m., and on July 27, 2001, from 8:30 a.m. to 3:30 p.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by July 8, 2001. On July 27, 2001, oral presentations will be held between approximately 9 a.m. and 10:15 a.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before July 8, 2001, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation.
Closed Committee Deliberations: On July 26, 2001, from 8:30 a.m. to 10:15 a.m., the meeting will be closed to permit discussion and review of trade secret and/or confidential information (5 U.S.C. 552b(c)(4)).
Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).Start Signature
Dated: June 19, 2001.
Special Assistant to the Senior Associate Commissioner.
[FR Doc. 01-15912 Filed 6-25-01; 8:45 am]
BILLING CODE 4160-01-S